KR100701490B1 - 마이코나졸 질산염으로 외음부질 칸디다증을 치료하는방법 및 키트 - Google Patents

마이코나졸 질산염으로 외음부질 칸디다증을 치료하는방법 및 키트 Download PDF

Info

Publication number
KR100701490B1
KR100701490B1 KR1020007007770A KR20007007770A KR100701490B1 KR 100701490 B1 KR100701490 B1 KR 100701490B1 KR 1020007007770 A KR1020007007770 A KR 1020007007770A KR 20007007770 A KR20007007770 A KR 20007007770A KR 100701490 B1 KR100701490 B1 KR 100701490B1
Authority
KR
South Korea
Prior art keywords
myconazole nitrate
myconazole
nitrate
cream
candidiasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020007007770A
Other languages
English (en)
Korean (ko)
Other versions
KR20010034150A (ko
Inventor
데이빗 에이치. 업멜리스
Original Assignee
맥네일-피피씨, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22727682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100701490(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 맥네일-피피씨, 인코포레이티드 filed Critical 맥네일-피피씨, 인코포레이티드
Publication of KR20010034150A publication Critical patent/KR20010034150A/ko
Application granted granted Critical
Publication of KR100701490B1 publication Critical patent/KR100701490B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020007007770A 1998-11-20 1999-11-15 마이코나졸 질산염으로 외음부질 칸디다증을 치료하는방법 및 키트 Expired - Fee Related KR100701490B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/197,019 US6153635A (en) 1998-11-20 1998-11-20 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
US09/197,019 1998-11-20
PCT/US1999/027091 WO2000030626A2 (en) 1998-11-20 1999-11-15 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate

Publications (2)

Publication Number Publication Date
KR20010034150A KR20010034150A (ko) 2001-04-25
KR100701490B1 true KR100701490B1 (ko) 2007-04-02

Family

ID=22727682

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007007770A Expired - Fee Related KR100701490B1 (ko) 1998-11-20 1999-11-15 마이코나졸 질산염으로 외음부질 칸디다증을 치료하는방법 및 키트

Country Status (13)

Country Link
US (1) US6153635A (https=)
EP (1) EP1051162B1 (https=)
JP (1) JP2002530327A (https=)
KR (1) KR100701490B1 (https=)
CN (1) CN1332663C (https=)
AR (1) AR021863A1 (https=)
AU (1) AU777508B2 (https=)
BR (1) BR9907150A (https=)
CA (1) CA2318125C (https=)
DE (1) DE69930725T2 (https=)
ES (1) ES2262353T3 (https=)
TW (1) TWI229599B (https=)
WO (1) WO2000030626A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE400270T1 (de) * 2002-12-18 2008-07-15 Ferrer Int Pharmazeutische zusammensetzungen mit sertaconazol für vaginale verwendung
EP1500394A1 (en) * 2003-07-22 2005-01-26 Polichem S.A. Pharmaceutical compositions comprising ascorbic acid or the treatment of fungal superinfections and fungal recurrences
CA2538991A1 (en) 2003-09-18 2005-03-31 Children's Medical Center Corporation Treatment of severe distal colitis
US20070065504A1 (en) * 2004-03-23 2007-03-22 Lin Shun Y Products and methods for treating vaginal infections
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
US8057433B2 (en) 2004-07-08 2011-11-15 Drugtech Corporation Delivery system
US20090156987A1 (en) * 2007-12-14 2009-06-18 Mclean Barbara Wanamaker Apparatus and method of delivery of substances into target tissue
WO2018013625A1 (en) * 2016-07-13 2018-01-18 Concert Pharmaceuticals, Inc. Deuterated miconazole
JP2025507426A (ja) * 2022-02-17 2025-03-18 ゼンビジョン ファルマ エルエルピー ミコナゾール及びルリコナゾール又はそれらの塩を含む膣用医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830405D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
논문 <URL:http;//www.monistat.com/pi_com3.html> *
논문 URL:http;//www.monistat.com/pi_com3.html

Also Published As

Publication number Publication date
KR20010034150A (ko) 2001-04-25
ES2262353T3 (es) 2006-11-16
EP1051162A1 (en) 2000-11-15
WO2000030626A2 (en) 2000-06-02
AU2024800A (en) 2000-06-13
TWI229599B (en) 2005-03-21
CA2318125A1 (en) 2000-06-02
WO2000030626A3 (en) 2000-11-23
CN1332663C (zh) 2007-08-22
EP1051162B1 (en) 2006-04-05
CN1288379A (zh) 2001-03-21
CA2318125C (en) 2005-03-08
AU777508B2 (en) 2004-10-21
US6153635A (en) 2000-11-28
DE69930725D1 (de) 2006-05-18
DE69930725T2 (de) 2007-04-12
BR9907150A (pt) 2000-10-24
AR021863A1 (es) 2002-08-07
HK1036930A1 (zh) 2002-01-25
JP2002530327A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
Raborn et al. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study
Hazen et al. Management of necrotizing vasculitis with colchicine: Improvement in patients with cutaneous lesions and Behçet's syndrome
Steere et al. Treatment of the early manifestations of Lyme disease
CN108853312B (zh) 聚桂醇外用凝胶及其制备方法
KR100701490B1 (ko) 마이코나졸 질산염으로 외음부질 칸디다증을 치료하는방법 및 키트
AU731286B2 (en) Composition and method for treating herpes simplex
US5886047A (en) Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
US4119713A (en) Analgesic and anti-inflammatory composition
Forssman et al. Treatment of recurrent vaginal candidiasis
Jose et al. Levamisole in patients with recurrent herpes infection
MXPA00007095A (en) Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
KR102784739B1 (ko) 질 세정용 조성물
AU2021106779A4 (en) Methods and Compositions for Improving Vaginal Health
Kivinen et al. Short-term topical treatment of wlvovaginal candidiasis with the combination of 5-fluorocytosine and candicidin
RU2481102C1 (ru) Способ комплексного лечения неспецифических воспалительных заболеваний женской половой сферы
HK1036930B (en) Kits for treating vulvovaginal candidiasis with miconazole nitrate
CROSBIE Treatment of a case of relapsing panniculitis with cortisone and ACTH
JP2007518797A (ja) 膣感染症の処置のための、フルコナゾール−チニダゾールの組み合わせ、ならびに、その組成物、調製プロセスおよび使用
Morejon et al. CASE REPORT–ADVANCED AIDS: DIAGNOSIS WITH THREE ASSOCIATED INFECTIONS: MPOX, KAPOSI SARCOMA AND HERPES ZOSTER
RU2326688C1 (ru) Гипоаллергенное лекарственное средство для лечения инфекционно-воспалительных заболеваний различной этиологии
Panja Treatment of trichomoniasis with metronidazole rectal suppositories
HRP20020201A2 (en) Pharmaceutical compositions for treating psoriasis
Claus et al. Treatment of acute ulcerative lesions of the oral cavity
CN118453704A (zh) 一种治疗女性hpv感染的中药
CN109939223A (zh) 一种白介素2在制备用于治疗寻常型天疱疮口腔糜烂药物的应用

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Not in force date: 20100324

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20100324

St.27 status event code: N-4-6-H10-H13-oth-PC1903

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

St.27 status event code: A-5-5-R10-R13-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000